None listed
Conditions
Brief summary
Objective: Mucositis is one of the common side effects of chemotherapy. This study aimed to identify the effects of honey on oral care interventions to reduce mucositis scores among children undergoing chemotherapy. Major Hypothesis: The main hypothesis in this study is that administering honey in oral care reduces chemotherapy-induced mucositis. Minor Hypothesis: (1) The intervention group had a lower mean mucositis score after oral care using honey than the control group. (2) The intervention group showed a lower mean difference in mucositis scores after oral care with honey than the control group. Methods: This pilot study was quasi-experimental with before-after intervention with the control group. The study employed consecutive sampling, with 24 patients in the control and 24 in the intervention group. The intervention group received an oral care protocol using honey, whereas the control group received regular standard oral care. The data were collected using a demographic information form and the mucositis score was observed using the Oral Assessment Guide (OAG). The intervention group received oral care intervention using honey (35 ml of honey applied topically in the oral cavity and 15 ml of honey used as a mouthwash and for lip care), which was given thrice daily for five days. The data were analyzed using percentage distributions, means, chi-square tests, dependent and independent t-tests, and multivariate analysis using analysis of covariance (ANCOVA).
Interventions
Before implementing the intervention, nurses and doctors will educate parents and children for approximately 60 minutes about oral care with honey. In this session, parents will learn how to perform basic oral care (toothbrushing, mouthwashing, and lip care). The nurse will also teach about the benefits of honey and how to use it in oral care, such as how to apply honey to the mouth, make a honey mouth rinse, and use honey as a lip care agent in children's oral care. The nurse demonstrates how to apply honey directly to the patient's oral cavity and lips and make honey mouthwash. Nurses and doctors also advise parents to provide oral care to their children at least three (3) times per day using honey for five (5) days. The honey administration protocol used in this study was based on that used in the Montalebnejad study. The intervention group will receive oral care through honey thrice daily (30 minutes after breakfast, lunch, and before sleep) for five days. Each oral care session lasts between 15-20 minutes (includes toothbrushing, mouthwashing, and lip care). For each oral care intervention, 35 mL of honey was applied topically in the oral cavity, and 15 mL was used as a mouthwash and lip care. The first application of honey in oral care to the patient will be done by the nurse. The nurse will apply honey to the oral cavity, and then give the patient honey mouthwash, and smear honey on the lips. The patient's parents will pay attention to the actions taken by the nurse. The next oral care application of honey was done by parents. The nurse provides parents with a daily activity book to monitor their compliance with the intervention. The book includes a daily oral care activity sheet, which must be completed every time parents provide oral care for their child. Apart from that, parental compliance is monitored by nurses directly observing parents' actions in providing oral care interventions to children for five (5) days while the child is in the hospital. In this study, Indonesian natural and standardized flower honey will administered to the intervention group, in addition to routine and standard care performed at the clinic after each chemotherapy session. The honey contains a flower honey from Indonesian forests that meets Indonesian national standards. The honey contained 17-20% (maximum water content of 22%), 60% sugar reduction, 10% sucrose, 40 ml NaOH/kg acidity, and the diastase enzyme activity of 8 DNs (minimum 3 DNs). These Indonesian honey samples contained minerals (Ca, Na, P, Fe, Mg, and Mn), vitamins (B1, B2, B5, B6, and C), and enzymes.
Sponsors
Study design
Eligibility
Inclusion criteria
Participants in this study are children with cancer who were undergoing chemotherapy at the children’s inpatient unit at one national referral hospital in Indonesia. Samples will taken by purposive sampling. The inclusion criteria are children who were receiving chemotherapy who were at least two years old and did not have impaired hepatic or renal functions. The patients had hematological values within the normal range.
Exclusion criteria
Exclusion criteria: Children with stage 3-4 nasopharyngeal cancer who had difficulty opening their mouths and could not receive oral care interventions were excluded from this study.